Seres Therapeutics Inc (MCRB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

200 SIDNEY STREET CAMBRIDGE, MA 02139

Seres Therapeutics, Inc. operates as a microbiome therapeutics platform company. The Company focuses on developing biological drugs, which are designed to restore health by repairing the function of a dysbiotic microbiome. Seres Therapeutics also conducts research on metabolic diseases.

Data as of 2020-08-09
Market Cap353.84 Million Shares Outstanding76.259 Million Avg 30-day Volume932.035 Thousand
P/E Ratio Dividend Yield EPS-1.04
Price/Sales12.249 Price cash flow ratio8.9 Price free cash flow ratio-4.3
Book Value-0.86 Price to Tangible Book-5.4 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.059377
BETA1.17688 52-week High/Low6.75 / 2.52 Stddev0.203095
View SEC Filings from MCRB instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 0 (0.0%)
13F Filers holding this stock: 79 16 (1.05%)
Aggregate 13F shares on 03/31/2020: 67.801 Million 20.016 Million
Aggregate 13F shares on 12/31/2019: 65.933 Million 12.137 Million
Percent change: 2.83% 64.91%
Funds creating new positions: 10
Funds Adding to an existing position: 28 7
Funds closing out their position: 9 2
Funds reducing their position: 25 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MCRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MCRB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

POMERANTZ ROGER

  • Director
0 2020-07-15 0

AUSIELLO DENNIS A

  • Director
0 2020-07-01 1

YOUNG TERESA L. SEE REMARKS

  • Officer
0 2020-06-29 2

DERE WILLARD H

  • Director
13,290 2020-06-26 1

HUTT PETER BARTON

  • Director
17,234 2020-06-18 0

KENDER RICHARD N

  • Director
0 2020-06-18 1

COOK DAVID N SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-06-18 0

BEHAR GREGORY

  • Director
0 2020-06-18 1

GRAVES KURT

  • Director
0 2020-06-18 1

ZAUSNER MERYL

  • Director
0 2020-06-18 1

BERENSON STEPHEN

  • Director
0 2020-06-18 1

BIONDI PAUL

  • Director
0 2020-06-18 3

KIM LORENCE H. CHIEF FINANCIAL OFFICER

  • Officer
1,202,510 2020-06-02 0

AFEYAN NOUBAR

  • Director
  • 10% Owner
0 2020-05-21 0

CHAPMAN MARCUS SEE REMARKS

  • Officer
0 2020-04-22 3

VON MOLTKE LISA SEE REMARKS

  • Officer
0 2020-04-06 2

SHAFF ERIC D. PRESIDENT CFO

  • Officer
0 2020-01-29 2

AUNINS JOHN G. CHIEF TECHNOLOGY OFFICER & EVP

  • Officer
0 2020-01-29 2

DESROSIER THOMAS CHIEF LEGAL OFFICER AND EVP

  • Officer
0 2020-01-29 2

HENN MATTHEW R. SEE REMARKS

  • Officer
0 2020-01-29 2

FLAGSHIP PIONEERING INC.

FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC

FLAGSHIP PIONEERING FUND VI, L.P.

NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

NUTRITIONAL HEALTH LTP FUND, L.P.

  • 10% Owner
4,444,444 2019-06-18 0

HORGAN KEVIN CHIEF MEDICAL OFFICER AND EVP

  • Officer
0 2019-01-25 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
11,727,113 2018-02-26 0

TRUCKSIS MICHELE SEE REMARKS

  • Officer
4,893 2018-01-26 0

CAUTREELS WERNER PRESIDENT AND CEO

  • Officer
  • Director
321,203 2017-11-13 0

HASHAD WAEL EVP & CHIEF COMMERCIAL OFFICER

  • Officer
0 2017-01-26 0

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
No longer subject to file 2016-09-22 0

AFEYAN NOUBAR

FLAGSHIP VENTURES FUND 2007, L.P.

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

FLAGSHIP VENTURELABS IV, LLC

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

KANIA EDWIN M JR

  • Director
  • 10% Owner
14,641,852 2016-05-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

YOUNG TERESA L. - Officer SEE REMARKS

2020-06-29 A 300,000 a 300,000 0.00 direct

BEHAR GREGORY - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

KENDER RICHARD N - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

AUSIELLO DENNIS A - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

BERENSON STEPHEN - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

DERE WILLARD H - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

BIONDI PAUL - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

ZAUSNER MERYL - Director

2020-06-18 A 30,000 a 30,000 0.00 direct

GRAVES KURT - Director

2020-06-18 A 30,000 a 30,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments